이부프로펜 시장 : 유형별, 용도별, 유통 채널별 - 세계 기회 분석과 산업 예측(2024-2033년)

Ibuprofen Market By Type , By Application By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2024-2033

US $ 4,425 ￦ 6,067,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,162,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

이부프로펜 시장

이부프로펜 시장은 2023년에 1억 달러로 평가되며, 2024-2033년 CAGR 7.9%로 성장하며, 2033년에는 2억 1,360만 달러에 달할 것으로 예측됩니다.

이부프로펜은 통증 완화, 염증 억제, 열을 낮추는 효능으로 널리 사용되는 비스테로이드성 항염증약입니다. 진통제에 속하며 두통, 근육통, 치통, 생리통, 관절염 등 경증에서 중등도의 통증을 완화하는 데 사용됩니다. 이 약의 작용기전은 통증과 염증을 유발하는 화합물인 체내 프로스타글란딘의 생성을 억제하는 것입니다.

이부프로펜은 여러 가지 건강 상태를 치료할 수 있는 다용도한 특성으로 인해 시장 성장의 주요 촉진요인으로 작용하고 있습니다. 또한 이부프로펜은 여러 국가에서 일반 의약품으로 판매되고 있으며, 셀프 메디케이션에 기여하고 고객의 편의성을 높이는 등 높은 수요를 목격하고 있습니다. 현재 시장은 의약품의 탈화석화라는 새로운 동향을 목격하고 있습니다. 이부프로펜의 전형적인 생산원은 원유입니다. 최근 바스 대학의 연구진은 제지 산업에서 발생하는 폐기물로 의약품을 개발할 수 있는 방법을 발견했습니다. 이 발견은 제약 산업이 지속가능성을 향한 큰 진전을 이루었습니다는 것을 의미합니다.

이부프로펜은 그 효능에도 불구하고 장기간 사용하면 심혈관계 위험, 위장 합병증, 신장 손상과 같은 심각한 부작용을 유발하는 것으로 알려져 있습니다. 이러한 요인으로 인해 많은 사람들이 약물 복용을 자제하고 시장 성장을 억제하고 있으며, British Medical Journal에 게재된 연구에 따르면 이부프로펜은 심장 마비 위험을 31% 증가시킬 것으로 예상됩니다. 또한 미국 국립과학원 회보(Proceedings of the National Academy of Sciences)에 발표된 연구에 따르면 건강한 젊은 남성이 이부프로펜을 다량으로 복용하면 생식 호르몬 분비가 감소하여 보상성 성선기능저하증이 발생한다고 합니다.

부문별 리뷰

이부프로펜 시장은 유형, 용도, 유통 채널, 지역으로 분류됩니다. 유형별로는 정제, 캡슐제, 시럽제, 주사제, 기타로 나뉩니다. 용도별로는 류마티스 관절염 및 골관절염, 암, 통증, 발열 및 월경통, 염증성 질환, 두통, 기타로 분류됩니다. 유통 채널에 따라 시장은 병원 약국, 소매 약국, 온라인 약국으로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 분석됩니다.

주요 조사 결과

유형별로는 2023년 정제 부문이 시장 점유율 1위를 차지했습니다.

용도별로는 류마티스 관절염 부문이 2023년 가장 높은 매출을 기록할 것으로 예상됩니다.

유통 채널별로는 병원 약국 부문이 2023년 높은 시장 점유율을 차지했습니다.

지역별로는 북미가 2033년까지 시장을 독점할 것으로 예상됩니다.

이 보고서는 사용자 정의가 가능합니다.

• 규제 가이드라인
• 고객의 관심사에 따른 기업 개요 추가
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 전망
• 기업 개요 확대 리스트
• 과거 시장 데이터
• 주요 진입기업 세부 정보(위치, 연락처, 공급업체/벤더 네트워크 등 포함, 엑셀 형식)

목차

제1장 서론

제2장 개요

제3장 시장 구도

• 시장의 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter's Five Forces 분석
• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회

제4장 이부프로펜 시장 : 유형별

• 시장 개요
• 정제
• 캡슐
• 시럽제
• 주사제
• 기타

제5장 이부프로펜 시장 : 용도별

• 시장 개요
• 류마티스 관절염과 골관절염
• 암
• 통증/발열/월경 곤란증
• 염증성 질환
• 두통
• 기타

제6장 이부프로펜 시장 : 유통 채널별

• 시장 개요
• 병원 약국
• 소매 약국
• 온라인 약국

제7장 이부프로펜 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국의 이부프로펜 시장
  • 캐나다의 이부프로펜 시장
  • 멕시코의 이부프로펜 시장
• 유럽
  • 주요 시장 동향과 기회
  • 독일의 이부프로펜 시장
  • 프랑스의 이부프로펜 시장
  • 영국의 이부프로펜 시장
  • 이탈리아의 이부프로펜 시장
  • 스페인의 이부프로펜 시장
  • 기타 유럽의 이부프로펜 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 일본의 이부프로펜 시장
  • 중국의 이부프로펜 시장
  • 호주의 이부프로펜 시장
  • 인도의 이부프로펜 시장
  • 한국의 이부프로펜 시장
  • 기타 아시아태평양의 이부프로펜 시장
• 라틴아메리카·중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질의 이부프로펜 시장
  • 사우디아라비아의 이부프로펜 시장
  • 남아프리카공화국의 이부프로펜 시장
  • 기타 라틴아메리카·중동 및 아프리카의 이부프로펜 시장

제8장 경쟁 구도

• 서론
• 주요 성공 전략
• 주요 기업 10사 제품 지도제작
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제9장 기업 개요

• Pfizer Inc.
• Abbott Laboratories
• Solara Active Pharma Sciences Ltd
• BASF SE
• Biocause Inc
• Shandong Xinhua Pharmaceutical Co Ltd
• IOL Chemicals And Pharmaceutical Ltd
• Hubei Biocause Pharmaceutical Co Ltd
• Strides Pharma Science Ltd
• Perrigo Company Plc

KSA

영문 목차

영문목차

Ibuprofen Market

The ibuprofen market was valued at $100.0 million in 2023 and is projected to reach $213.6 million by 2033, growing at a CAGR of 7.9% from 2024 to 2033.

Ibuprofen is a nonsteroidal anti-inflammatory drug popular for its efficacy in alleviating pain, reducing inflammation, and lowering fever. It belongs to the analgesics class of medications which are used to ease mild to moderate pain, such as headaches, muscle aches, toothaches, menstrual cramps, and arthritis. The action mechanism of the medication involves inhibiting the production of prostaglandins inside the body, compounds that are the cause of pain and inflammation.

The versatility of ibuprofen in treating several health conditions is a key driver of the market. In addition, ibuprofen witnesses a high demand in several countries where it is accessible as over-the-counter medication, hence contributing to self-medication and elevating the convenience of customers. The market is currently witnessing an emerging trend of de-fossilization of pharmaceuticals. The typical source of formation of ibuprofen is from crude oils. Researchers at the University of Bath have recently discovered a method to develop the medication out of waste generated from the paper manufacturing industry. This discovery marks a significant step by the pharmaceuticals industry toward sustainability.

Despite its benefits, long-term usage of ibuprofen is known to cause severe side-effects such as cardiovascular risks, gastrointestinal complications, and kidney damage. These factors deter several individuals from the consumption of medication, hence restraining the market growth. According to a study posted by the British Medical Journal, ibuprofen is anticipated to elevate the risk of cardiac arrests by 31%. In a similar way, a study published in the Proceedings of the National Academy of Sciences states that high uptake of ibuprofen in young healthy men results in less production of reproductive hormones and occurrence of compensated hypogonadism disorder.

Segment Review

The ibuprofen market is segmented into type, application, distribution channel, and region. On the basis of type, the market is divided into tablet, capsule, syrup, injection, and others. As per application, it is classified into rheumatoid arthritis & osteoarthritis, cancer, pain/fever/dysmenorrhea, inflammatory diseases, headache, and others. Depending on distribution channel, the market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the tablet segment dominated the market share in 2023.

As per application, the rheumatoid arthritis segment generated the highest revenue in 2023.

Depending on distribution channel, the hospital pharmacies segment acquired a high market share in 2023.

Region wise, North America is expected to dominate the market by 2033.

Competition Analysis

The major players operating in the global ibuprofen market include Pfizer Inc., Abbott Laboratories Ltd., Solara Active Pharma Sciences Ltd., ?h?nd?ng ??nhu? ?h?rm???ut???l ??.Ltd, ??L ?h?m???l? and ?h?rm???ut???l L?m?t?d, ?ub?? ?????u?? ?h?rm???ut???l ??.Ltd, ?tr?d?? ?h?rm? ????n?? L?m?t?d (?h??un ?h?rm???ut???l? L?m?t?d), ??rr?g? ??m??n? ?l?, BASF SE, and Biocause Inc. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

• Tablet
• Capsule
• Syrup
• Injection
• Others

By Application

• Rheumatoid Arthritis and Osteoarthritis
• Cancer
• Pain/Fever/Dysmenorrhea
• Inflammatory Diseases
• Headache
• Others

By Distribution Channel

• Hospital pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Pfizer Inc.
• Abbott Laboratories
• Solara Active Pharma Sciences Ltd
• BASF SE
• Biocause Inc
• Shandong Xinhua Pharmaceutical Co Ltd
• IOL Chemicals and Pharmaceutical Ltd
• Hubei Biocause Pharmaceutical Co Ltd
• Strides Pharma Science Ltd
• Perrigo Company Plc

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.4. Market Dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: IBUPROFEN MARKET, BY TYPE

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Type
• 4.2. Tablet
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Capsule
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country
• 4.4. Syrup
  • 4.4.1. Key Market Trends, Growth Factors and Opportunities
  • 4.4.2. Market Size and Forecast, By Region
  • 4.4.3. Market Share Analysis, By Country
• 4.5. Injection
  • 4.5.1. Key Market Trends, Growth Factors and Opportunities
  • 4.5.2. Market Size and Forecast, By Region
  • 4.5.3. Market Share Analysis, By Country
• 4.6. Others
  • 4.6.1. Key Market Trends, Growth Factors and Opportunities
  • 4.6.2. Market Size and Forecast, By Region
  • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: IBUPROFEN MARKET, BY APPLICATION

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By Application
• 5.2. Rheumatoid Arthritis And Osteoarthritis
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Cancer
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country
• 5.4. Pain/Fever/Dysmenorrhea
  • 5.4.1. Key Market Trends, Growth Factors and Opportunities
  • 5.4.2. Market Size and Forecast, By Region
  • 5.4.3. Market Share Analysis, By Country
• 5.5. Inflammatory Diseases
  • 5.5.1. Key Market Trends, Growth Factors and Opportunities
  • 5.5.2. Market Size and Forecast, By Region
  • 5.5.3. Market Share Analysis, By Country
• 5.6. Headache
  • 5.6.1. Key Market Trends, Growth Factors and Opportunities
  • 5.6.2. Market Size and Forecast, By Region
  • 5.6.3. Market Share Analysis, By Country
• 5.7. Others
  • 5.7.1. Key Market Trends, Growth Factors and Opportunities
  • 5.7.2. Market Size and Forecast, By Region
  • 5.7.3. Market Share Analysis, By Country

CHAPTER 6: IBUPROFEN MARKET, BY DISTRIBUTION CHANNEL

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By Distribution Channel
• 6.2. Hospital Pharmacies
  • 6.2.1. Key Market Trends, Growth Factors and Opportunities
  • 6.2.2. Market Size and Forecast, By Region
  • 6.2.3. Market Share Analysis, By Country
• 6.3. Retail Pharmacies
  • 6.3.1. Key Market Trends, Growth Factors and Opportunities
  • 6.3.2. Market Size and Forecast, By Region
  • 6.3.3. Market Share Analysis, By Country
• 6.4. Online Pharmacies
  • 6.4.1. Key Market Trends, Growth Factors and Opportunities
  • 6.4.2. Market Size and Forecast, By Region
  • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: IBUPROFEN MARKET, BY REGION

• 7.1. Market Overview
  • 7.1.1 Market Size and Forecast, By Region
• 7.2. North America
  • 7.2.1. Key Market Trends and Opportunities
  • 7.2.2. Market Size and Forecast, By Type
  • 7.2.3. Market Size and Forecast, By Application
  • 7.2.4. Market Size and Forecast, By Distribution Channel
  • 7.2.5. Market Size and Forecast, By Country
  • 7.2.6. U.S. Ibuprofen Market
    • 7.2.6.1. Market Size and Forecast, By Type
    • 7.2.6.2. Market Size and Forecast, By Application
    • 7.2.6.3. Market Size and Forecast, By Distribution Channel
  • 7.2.7. Canada Ibuprofen Market
    • 7.2.7.1. Market Size and Forecast, By Type
    • 7.2.7.2. Market Size and Forecast, By Application
    • 7.2.7.3. Market Size and Forecast, By Distribution Channel
  • 7.2.8. Mexico Ibuprofen Market
    • 7.2.8.1. Market Size and Forecast, By Type
    • 7.2.8.2. Market Size and Forecast, By Application
    • 7.2.8.3. Market Size and Forecast, By Distribution Channel
• 7.3. Europe
  • 7.3.1. Key Market Trends and Opportunities
  • 7.3.2. Market Size and Forecast, By Type
  • 7.3.3. Market Size and Forecast, By Application
  • 7.3.4. Market Size and Forecast, By Distribution Channel
  • 7.3.5. Market Size and Forecast, By Country
  • 7.3.6. Germany Ibuprofen Market
    • 7.3.6.1. Market Size and Forecast, By Type
    • 7.3.6.2. Market Size and Forecast, By Application
    • 7.3.6.3. Market Size and Forecast, By Distribution Channel
  • 7.3.7. France Ibuprofen Market
    • 7.3.7.1. Market Size and Forecast, By Type
    • 7.3.7.2. Market Size and Forecast, By Application
    • 7.3.7.3. Market Size and Forecast, By Distribution Channel
  • 7.3.8. UK Ibuprofen Market
    • 7.3.8.1. Market Size and Forecast, By Type
    • 7.3.8.2. Market Size and Forecast, By Application
    • 7.3.8.3. Market Size and Forecast, By Distribution Channel
  • 7.3.9. Italy Ibuprofen Market
    • 7.3.9.1. Market Size and Forecast, By Type
    • 7.3.9.2. Market Size and Forecast, By Application
    • 7.3.9.3. Market Size and Forecast, By Distribution Channel
  • 7.3.10. Spain Ibuprofen Market
    • 7.3.10.1. Market Size and Forecast, By Type
    • 7.3.10.2. Market Size and Forecast, By Application
    • 7.3.10.3. Market Size and Forecast, By Distribution Channel
  • 7.3.11. Rest of Europe Ibuprofen Market
    • 7.3.11.1. Market Size and Forecast, By Type
    • 7.3.11.2. Market Size and Forecast, By Application
    • 7.3.11.3. Market Size and Forecast, By Distribution Channel
• 7.4. Asia-Pacific
  • 7.4.1. Key Market Trends and Opportunities
  • 7.4.2. Market Size and Forecast, By Type
  • 7.4.3. Market Size and Forecast, By Application
  • 7.4.4. Market Size and Forecast, By Distribution Channel
  • 7.4.5. Market Size and Forecast, By Country
  • 7.4.6. Japan Ibuprofen Market
    • 7.4.6.1. Market Size and Forecast, By Type
    • 7.4.6.2. Market Size and Forecast, By Application
    • 7.4.6.3. Market Size and Forecast, By Distribution Channel
  • 7.4.7. China Ibuprofen Market
    • 7.4.7.1. Market Size and Forecast, By Type
    • 7.4.7.2. Market Size and Forecast, By Application
    • 7.4.7.3. Market Size and Forecast, By Distribution Channel
  • 7.4.8. Australia Ibuprofen Market
    • 7.4.8.1. Market Size and Forecast, By Type
    • 7.4.8.2. Market Size and Forecast, By Application
    • 7.4.8.3. Market Size and Forecast, By Distribution Channel
  • 7.4.9. India Ibuprofen Market
    • 7.4.9.1. Market Size and Forecast, By Type
    • 7.4.9.2. Market Size and Forecast, By Application
    • 7.4.9.3. Market Size and Forecast, By Distribution Channel
  • 7.4.10. South Korea Ibuprofen Market
    • 7.4.10.1. Market Size and Forecast, By Type
    • 7.4.10.2. Market Size and Forecast, By Application
    • 7.4.10.3. Market Size and Forecast, By Distribution Channel
  • 7.4.11. Rest of Asia-Pacific Ibuprofen Market
    • 7.4.11.1. Market Size and Forecast, By Type
    • 7.4.11.2. Market Size and Forecast, By Application
    • 7.4.11.3. Market Size and Forecast, By Distribution Channel
• 7.5. LAMEA
  • 7.5.1. Key Market Trends and Opportunities
  • 7.5.2. Market Size and Forecast, By Type
  • 7.5.3. Market Size and Forecast, By Application
  • 7.5.4. Market Size and Forecast, By Distribution Channel
  • 7.5.5. Market Size and Forecast, By Country
  • 7.5.6. Brazil Ibuprofen Market
    • 7.5.6.1. Market Size and Forecast, By Type
    • 7.5.6.2. Market Size and Forecast, By Application
    • 7.5.6.3. Market Size and Forecast, By Distribution Channel
  • 7.5.7. Saudi Arabia Ibuprofen Market
    • 7.5.7.1. Market Size and Forecast, By Type
    • 7.5.7.2. Market Size and Forecast, By Application
    • 7.5.7.3. Market Size and Forecast, By Distribution Channel
  • 7.5.8. South Africa Ibuprofen Market
    • 7.5.8.1. Market Size and Forecast, By Type
    • 7.5.8.2. Market Size and Forecast, By Application
    • 7.5.8.3. Market Size and Forecast, By Distribution Channel
  • 7.5.9. Rest of LAMEA Ibuprofen Market
    • 7.5.9.1. Market Size and Forecast, By Type
    • 7.5.9.2. Market Size and Forecast, By Application
    • 7.5.9.3. Market Size and Forecast, By Distribution Channel

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top Winning Strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

• 9.1. Pfizer Inc.
  • 9.1.1. Company Overview
  • 9.1.2. Key Executives
  • 9.1.3. Company Snapshot
  • 9.1.4. Operating Business Segments
  • 9.1.5. Product Portfolio
  • 9.1.6. Business Performance
  • 9.1.7. Key Strategic Moves and Developments
• 9.2. Abbott Laboratories
  • 9.2.1. Company Overview
  • 9.2.2. Key Executives
  • 9.2.3. Company Snapshot
  • 9.2.4. Operating Business Segments
  • 9.2.5. Product Portfolio
  • 9.2.6. Business Performance
  • 9.2.7. Key Strategic Moves and Developments
• 9.3. Solara Active Pharma Sciences Ltd
  • 9.3.1. Company Overview
  • 9.3.2. Key Executives
  • 9.3.3. Company Snapshot
  • 9.3.4. Operating Business Segments
  • 9.3.5. Product Portfolio
  • 9.3.6. Business Performance
  • 9.3.7. Key Strategic Moves and Developments
• 9.4. BASF SE
  • 9.4.1. Company Overview
  • 9.4.2. Key Executives
  • 9.4.3. Company Snapshot
  • 9.4.4. Operating Business Segments
  • 9.4.5. Product Portfolio
  • 9.4.6. Business Performance
  • 9.4.7. Key Strategic Moves and Developments
• 9.5. Biocause Inc
  • 9.5.1. Company Overview
  • 9.5.2. Key Executives
  • 9.5.3. Company Snapshot
  • 9.5.4. Operating Business Segments
  • 9.5.5. Product Portfolio
  • 9.5.6. Business Performance
  • 9.5.7. Key Strategic Moves and Developments
• 9.6. Shandong Xinhua Pharmaceutical Co Ltd
  • 9.6.1. Company Overview
  • 9.6.2. Key Executives
  • 9.6.3. Company Snapshot
  • 9.6.4. Operating Business Segments
  • 9.6.5. Product Portfolio
  • 9.6.6. Business Performance
  • 9.6.7. Key Strategic Moves and Developments
• 9.7. IOL Chemicals And Pharmaceutical Ltd
  • 9.7.1. Company Overview
  • 9.7.2. Key Executives
  • 9.7.3. Company Snapshot
  • 9.7.4. Operating Business Segments
  • 9.7.5. Product Portfolio
  • 9.7.6. Business Performance
  • 9.7.7. Key Strategic Moves and Developments
• 9.8. Hubei Biocause Pharmaceutical Co Ltd
  • 9.8.1. Company Overview
  • 9.8.2. Key Executives
  • 9.8.3. Company Snapshot
  • 9.8.4. Operating Business Segments
  • 9.8.5. Product Portfolio
  • 9.8.6. Business Performance
  • 9.8.7. Key Strategic Moves and Developments
• 9.9. Strides Pharma Science Ltd
  • 9.9.1. Company Overview
  • 9.9.2. Key Executives
  • 9.9.3. Company Snapshot
  • 9.9.4. Operating Business Segments
  • 9.9.5. Product Portfolio
  • 9.9.6. Business Performance
  • 9.9.7. Key Strategic Moves and Developments
• 9.10. Perrigo Company Plc
  • 9.10.1. Company Overview
  • 9.10.2. Key Executives
  • 9.10.3. Company Snapshot
  • 9.10.4. Operating Business Segments
  • 9.10.5. Product Portfolio
  • 9.10.6. Business Performance
  • 9.10.7. Key Strategic Moves and Developments

관련자료